Published in J Immunol on October 01, 1976
B lymphocytes secrete antigen-presenting vesicles. J Exp Med (1996) 11.53
On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J Exp Med (1978) 9.51
The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27
Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J Exp Med (1980) 1.96
Class I transplantation antigens in solution in body fluids and in the urine. Individuality signals to the environment. J Exp Med (1988) 1.39
Thymic reconstitution of nude F1 mice with one or both parental thymus grafts. J Exp Med (1979) 1.06
Isolation of BPgp70, a fibroblast receptor for the envelope antigen of Rauscher murine leukemia virus. Proc Natl Acad Sci U S A (1980) 0.95
Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy. Immunology (2002) 0.77
An immunosuppressive lipoprotein fraction from TEPC-183 bearing mice. Clin Exp Immunol (1983) 0.75
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell (1994) 9.51
On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J Exp Med (1978) 9.51
A procedure for rapid and sensitive staining of protein fractionated by polyacrylamide gel electrophoresis. Anal Biochem (1967) 7.96
Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest (2001) 5.94
The major histocompatibility complex of the mouse. Science (1979) 4.76
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A (1983) 4.56
Protein iodination with solid state lactoperoxidase. Biochemistry (1974) 4.52
Divergence time and population size in the lineage leading to modern humans. Theor Popul Biol (1995) 4.31
The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol (2000) 4.23
Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med (1972) 3.96
Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science (1966) 3.88
The H-2 model for the major histocompatibility systems. Transplant Rev (1971) 3.82
List of congenic lines of mice. I. Lines with differences at alloantigen loci. Transplantation (1973) 3.73
Bracteomania, an inflorescence anomaly, is caused by the loss of function of the MADS-box gene squamosa in Antirrhinum majus. EMBO J (1992) 3.60
Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34
Serological identification of an Ir-region product. Science (1973) 3.32
The traditional and a new version of the mouse H-2 complex. Nature (1981) 3.12
Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide. Clin Immunol Immunopathol (1975) 3.11
Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (2001) 2.79
Initiation of protein synthesis at an unusual position in an immunoglobulin gene? Science (1972) 2.74
MHC polymorphism pre-dating speciation. Nature (1988) 2.70
Therapy for acute otitis media. Preference of parents for oral or parenteral antibiotic. Arch Pediatr Adolesc Med (1996) 2.68
The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med (1973) 2.68
H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics (1983) 2.62
Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr (1988) 2.62
Origin of major histocompatibility complex polymorphism: the trans-species hypothesis. Hum Immunol (1987) 2.51
Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature (1978) 2.51
The polymer mat: arrested rebound of a compressed polymer layer. Eur Phys J E Soft Matter (2002) 2.43
Phylogeny of Darwin's finches as revealed by mtDNA sequences. Proc Natl Acad Sci U S A (1999) 2.42
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Polymorphism and balancing selection at major histocompatibility complex loci. Genetics (1992) 2.34
Directly measured second hand smoke exposure and asthma health outcomes. Thorax (2005) 2.32
Molecular characterisation of the Arabidopsis SBP-box genes. Gene (1999) 2.31
Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci U S A (1994) 2.30
Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiquronium bromide (AET) -treated sheep red blood cells with monkey red blood cells. J Immunol Methods (1976) 2.30
Expression of Ia-like antigens in normal human nonlymphoid tissues. Transplantation (1981) 2.29
Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. J Exp Med (1978) 2.24
Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci U S A (1982) 2.21
Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol (2001) 2.19
Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA (1994) 2.18
Salt extraction of soluble HL-A antigens. Science (1971) 2.18
Evolution of the major histocompatibility complex. Crit Rev Immunol (1986) 2.16
Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol (2001) 2.14
Degradation of phenanthrene, fluorene and fluoranthene by pure bacterial cultures. Appl Microbiol Biotechnol (1990) 2.12
H-2 mutations: their genetics and effect on immune functions. Adv Immunol (1978) 2.11
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest (1991) 2.08
Separation of 7S gamma-1-globulin, 7S gamma-2-globulin and macroglobulin guinea pig antibodies. Proc Soc Exp Biol Med (1966) 2.08
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A (1992) 2.07
Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res (1984) 2.01
Nucleotide sequences of chimpanzee MHC class I alleles: evidence for trans-species mode of evolution. EMBO J (1988) 1.98
Serologic evidence for antigens controlled by the Ir region in mice. J Exp Med (1973) 1.94
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N Engl J Med (1990) 1.91
Graft-versus-host reactions across different regions of the H-2 complex of the mouse. J Exp Med (1973) 1.87
Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med (1990) 1.83
Antigen-processing machinery breakdown and tumor growth. Immunol Today (2000) 1.82
Fluidity of water confined to subnanometre films. Nature (2001) 1.80
Structural studies of murine I-E and human DR antigens. Mol Immunol (1979) 1.79
Tissue distribution of I region-associated antigens in the mouse. J Immunol (1974) 1.76
Production of anti-H-2 antibodies in thymectomized mice. Eur J Immunol (1974) 1.74
DNA archives and our nearest relative: the trichotomy problem revisited. Mol Phylogenet Evol (2000) 1.71
H-2 types of translocation stocks T(2;9)138Ca, T(9;13)-190Ca and an H-2 recombinant. Transplantation (1970) 1.71
Evidence supporting a two-gene model for the H-2 histocompatibility system of the mouse. J Exp Med (1972) 1.70
Transplantation antigens. Adv Immunol (1970) 1.70
Murine Ia and human DR antigens: homology of amino-terminal sequences. Proc Natl Acad Sci U S A (1978) 1.70
Characterization of the WIDR: a human colon carcinoma cell line. In Vitro (1979) 1.69
Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2. Cancer Res (1990) 1.69
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer (2011) 1.69
Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today (1995) 1.69
Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Cancer Res (1987) 1.68
Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem (2000) 1.67
Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol (1998) 1.67
Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol (1990) 1.66
Genetics of the major histocompatibility complex: the final act. Annu Rev Immunol (1983) 1.65
Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow. J Natl Cancer Inst (1997) 1.64
Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent? Anaesthesia (2009) 1.64
Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood (1998) 1.64
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Neurology (2007) 1.63
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer (1997) 1.63
DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization. J Exp Med (1979) 1.63
Structural polymorphism of human DR antigens. Nature (1979) 1.63
Polymorphism of the mouse H-2 loci. Immunol Rev (1981) 1.63
Determination of gestational cocaine exposure by hair analysis. JAMA (1989) 1.63
Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol (1990) 1.61
Graft versus host reaction in strains of mice identical for H-2K and H-2D antigens. Nat New Biol (1973) 1.61
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer (1995) 1.59
Intensity of natural selection at the major histocompatibility complex loci. Proc Natl Acad Sci U S A (1994) 1.59
The origin and age of haplochromine fishes in Lake Victoria, east Africa. Proc Biol Sci (2000) 1.59
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene (2008) 1.59
In irradiation chimeras, K or D regions of the chimeric host, not of the donor lymphocytes, determine immune responsiveness of antiviral cytotoxic T cells. J Exp Med (1978) 1.57